BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chiu CT, Chiang JM, Yeh TS, Tseng JH, Chen TC, Jan YY, Chen MF. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges? Dig Liver Dis 2008;40:749-54. [PMID: 18329969 DOI: 10.1016/j.dld.2008.01.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Cardinale V, Semeraro R, Torrice A, Gatto M, Napoli C, Bragazzi MC, Gentile R, Alvaro D. Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors. World J Gastrointest Oncol 2010; 2(11): 407-416 [PMID: 21160904 DOI: 10.4251/wjgo.v2.i11.407] [Cited by in CrossRef: 114] [Cited by in F6Publishing: 152] [Article Influence: 9.5] [Reference Citation Analysis]
2 Zeng H, Shi G, Mai S, Liu H, Wu Z. Imaging and clinical features of colorectal liver metastases with macroscopic intrabiliary growth. Eur J Radiol 2021;137:109616. [PMID: 33676138 DOI: 10.1016/j.ejrad.2021.109616] [Reference Citation Analysis]
3 Jhaveri KS, Halankar J, Aguirre D, Haider M, Lockwood G, Guindi M, Fischer S. Intrahepatic Bile Duct Dilatation Due to Liver Metastases From Colorectal Carcinoma. American Journal of Roentgenology 2009;193:752-6. [DOI: 10.2214/ajr.08.2182] [Cited by in Crossref: 24] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
4 Cardinale V, Wang Y, Carpino G, Cui CB, Gatto M, Rossi M, Berloco PB, Cantafora A, Wauthier E, Furth ME, Inverardi L, Dominguez-Bendala J, Ricordi C, Gerber D, Gaudio E, Alvaro D, Reid L. Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology. 2011;54:2159-2172. [PMID: 21809358 DOI: 10.1002/hep.24590] [Cited by in Crossref: 213] [Cited by in F6Publishing: 186] [Article Influence: 21.3] [Reference Citation Analysis]
5 Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, Alexander DD, Choti MA, Poston G. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283-301. [PMID: 23152705 DOI: 10.2147/clep.s34285] [Cited by in Crossref: 67] [Cited by in F6Publishing: 154] [Article Influence: 6.7] [Reference Citation Analysis]
6 Al Ansari N, Kim BS, Srirattanapong S, Semelka CT, Ramalho M, Altun E, Woosley JT, Calvo B, Semelka RC. Mass-forming cholangiocarcinoma and adenocarcinoma of unknown primary: can they be distinguished on liver MRI? Abdom Imaging. 2014;39:1228-1240. [PMID: 24929668 DOI: 10.1007/s00261-014-0172-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Fu Y, Yang W, Wu W, Yan K, Xing BC, Chen MH. Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma. J Vasc Interv Radiol 2012;23:642-9. [PMID: 22525022 DOI: 10.1016/j.jvir.2012.01.081] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
8 Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T. Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma. Ann Surg Oncol 2008;15:2787-94. [DOI: 10.1245/s10434-008-0081-1] [Cited by in Crossref: 100] [Cited by in F6Publishing: 96] [Article Influence: 7.1] [Reference Citation Analysis]
9 Baheti AD, Tirumani SH, Rosenthal MH, Shinagare AB, Ramaiya NH. Diagnosis and management of intrahepatic cholangiocarcinoma: a comprehensive update for the radiologist. Clin Radiol. 2014;69:e463-e470. [PMID: 25240565 DOI: 10.1016/j.crad.2014.08.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
10 Wu C, Yeh Y, Tsuei Y, Huang L, Lin C, Liu C, Tseng H, Chiou Y, Chiu N. Comparative radiological pathological study of biliary intraductal tubulopapillary neoplasm and biliary intraductal papillary mucinous neoplasm. Abdom Radiol 2017;42:2460-9. [DOI: 10.1007/s00261-017-1167-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
11 Yao KJ, Jabbour S, Parekh N, Lin Y, Moss RA. Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database. BMC Gastroenterol. 2016;16:117. [PMID: 27655244 DOI: 10.1186/s12876-016-0527-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
12 Park JW, Jeong JM, Cho KS, Cho SY, Cheon JH, Choi DH, Park SJ, Kim HK. MiR-30a and miR-200c differentiate cholangiocarcinomas from gastrointestinal cancer liver metastases. PLoS One 2021;16:e0250083. [PMID: 33852640 DOI: 10.1371/journal.pone.0250083] [Reference Citation Analysis]
13 Tang H, Wang Z, Lv W, Meng X. The expression and clinicopathological role of CDX2 in intrahepatic cholangiocarcinoma. Intractable Rare Dis Res 2018;7:106-11. [PMID: 29862152 DOI: 10.5582/irdr.2018.01047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]